Quote:

---

Once again, using the same assumptions, the addition of 5 patients can increase the power in approximately 6%. As we know, it is critical for us to have extremely good results as this is P2 and we need FDA to approve Lero in basis of these.

---

I forgot to mention that the addition of 5 patients refers to 5 patients in the placebo arm, meaning 10 more in the Leronlimab arm (total 90 patients instead of 75).

Apologies for the initial lack of clarity.